Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanisms

Antitumour activity of docetaxel (Taxotere®) in hormone-dependent (HD) and hormone-independent (HID) prostate cancer PAC120 xenograft model was previously reported, and its level was associated with HER2 protein expression. In the present study, we evaluate the antitumour effects of docetaxel combin...

Descripción completa

Detalles Bibliográficos
Autores principales: Legrier, M-E, Oudard, S, Judde, J-G, Guyader, C, de Pinieux, G, Boyé, K, de Cremoux, P, Dutrillaux, B, Poupon, M-F
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359985/
https://www.ncbi.nlm.nih.gov/pubmed/17211467
http://dx.doi.org/10.1038/sj.bjc.6603553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359985/
https://www.ncbi.nlm.nih.gov/pubmed/17211467
http://dx.doi.org/10.1038/sj.bjc.6603553

Ejemplares similares